(MedPage Today) -- NEW ORLEANS -- Obstructive sleep apnea (OSA) in young children tripled the likelihood of new-onset glaucoma, a large retrospective analysis showed. Though still an uncommon condition in children, an unadjusted analysis showed...
(MedPage Today) -- Clinical obesity increased among U.S. adolescents over the past two decades, underscoring the urgent need for targeted prevention and intervention. According to a serial cross-sectional analysis of National Health and Nutrition...
(MedPage Today) -- A supplement marketed for joint pain and arthritis was the likely culprit in one man's iatrogenic Cushing's syndrome, researchers reported. A man in his 40s presented with features of Cushing's syndrome, including rapid weight...
(MedPage Today) -- Microvascular hemodynamics might provide an early marker of poor recovery despite successful large-vessel thrombectomy in acute ischemic stroke, an imaging study suggested. Poor capillary bed perfusion as indicated by relative...
(MedPage Today) -- Note that some links may require registration or subscription. Pope Leo XIV announced he will undergo surgery "in the coming days" to remove a nodule on his lung, in the first major health event of his 17-month…
Legislation introduced last week by Rep. Frank Pallone, D-N.J., would get rid of the arbitration process set up by the No Surprises Act entirely, the latest sign of growing interest on the Hill to reform the consumer protection law.
Another round of healthcare industry earnings reports kicked off Tuesday morning, with UnitedHealth Group reporting $4.1 billion in profit for the third quarter.
Two Thoreau-backed healthcare companies are partnering to bring real-time payer policy intelligence into revenue cycle workflows. The aim is to move claims denial management upstream into denial prevention, the companies said.
Asahi Kasei’s Hovilpri is now approved for treating lesions caused by herpes simplex virus infection. This daily pill came from the $919 million acquisition of AiCuris Anti-Infective Cures. The post Asahi Kasei Acquisition Pays Off With FDA Approval for Novel…
Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group and Pave Health Ventures. The post Outro Raises $7M To Support Safe Deprescribing appeared first on MedCity News .